Bibliographic Details
| Title: |
Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma. |
| Authors: |
Van Buren G 2nd; Division of Surgical Oncology, UPMC Pancreatic Cancer Center, Pittsburgh, PA, USA., Ramanathan RK, Krasinskas AM, Smith RP, Abood GJ, Bahary N, Lembersky BC, Shuai Y, Potter DM, Bartlett DL, Zureikat AH, Zeh HJ, Moser AJ |
| Source: |
Annals of surgical oncology [Ann Surg Oncol] 2013 Nov; Vol. 20 (12), pp. 3787-93. Date of Electronic Publication: 2013 Aug 01. |
| Publication Type: |
Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
